Spironolactone use and the risk of upper gastrointestinal bleeding: A population-based case-control study

British Journal of Clinical Pharmacology

Volumn 66, Issue 2, 2008, Pages 294-299

  Gulmez, Sinem E ^a,b   Lassen, Annmarie T ^c   Aalykke, Claus ^c   Dall, Michael ^c   Andries, Alin ^c   Andersen, Birthe S ^c   Hansen, Jane M ^c   Andersen, Morten ^c   Hallas, Jesper ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antithrombotic drugs; Case control study; Spironolactone; Upper gastrointestinal bleeding

Indexed keywords

ACETYLSALICYLIC ACID; AMILORIDE; ANTICOAGULANT AGENT; ANTIVITAMIN K; CLOPIDOGREL; DIPYRIDAMOLE; LOOP DIURETIC AGENT; POTASSIUM; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; HIGH RISK PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UPPER GASTROINTESTINAL BLEEDING;

EID: 47249149258     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03205.x     Document Type: Article

References (18)

1. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study investigators. N Engl J Med 1999 341 : 709 17.
2. Sato A, Suzuki Y, Saruta T. Effects of spironolactone and angiotensin converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertension. Hypertens Res 1999 22 : 17 22.
3. Modena MG, Aveta P, Menozzi A, Rossi R. Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction. Am Heart J 2001 141 : 41 6.
4. Mackay A, Stevenson RD. Gastric ulceration induced by spironolactone. Lancet 1977 1 : 481.
5. Kremer D, Fraser R, Brown JJ, Lever AF, Davies DL, Robertson JI. Amiloride in primary hyperaldosteronism with chronic peptic ulceration. BMJ 1973 2 : 216 7.
6. Trewby PN. Drug-induced peptic ulcer and upper gastrointestinal bleeding. Br J Hosp Med 1980 23 : 185 8, 190.
7. Verhamme K, Mosis G, Dieleman J, Stricker B, Sturkenboom M. Spironolactone and risk of upper gastrointestinal events: population based case-control study. BMJ 2006 333 : 330 3.
8. Slight SH, Chilakamarri VK, Nasr S, Dhalla AK, Ramires FJ, Sun Y, Ganjam VK, Weber KT. Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation. Mol Cell Biochem 1998 189 : 47 54.
9. Hallas J, Sørensen HT. Farmakoepidemiologi. Ugeskr Laeger 2005 167 : 2186 90.
10. Gaist D, Sørensen HT, Hallas J. The Danish prescription registers. Dan Med Bull 1997 44 : 445 8.
11. Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, Andersen M, Lassen AT. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006 333 : 726 30.
12. Rothman KJ. Measuring disease occurrence and casual effects. In : Epidemiology: an Introduction. New York : Oxford University Press Inc., 2002 24 56.
13. Hallas J, Gaist D, Bjerrum L. The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization. Epidemiology 1997 8 : 666 70.
14. Bjerre LM, LeLorier J. Expressing the magnitude of adverse effects in case-control studies: 'the number of patients needed to be treated for one additional patient to be harmed BMJ 2000 320 : 503 6.
15. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998 317 : 1309 12.
16. Hernandez-Diaz S, Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000 160 : 2093 9.
17. Weil J, Langman MJ, Wainwright P, Lawson DH, Rawlins M, Logan RF, Brown TP, Vessey MP, Murphy M, Colin-Jones DG. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000 46 : 27 31.
18. Laine L. Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk? Aliment Pharmacol Ther 2006 24 : 897 908.